Fu Gao
gaof@im.ac.cn
English, Chinese
Beijing
University of Chinese Academy of Sciences
Medical School
  • 1991-1994 PhD: Oxford University
  • 1983-1986 Master's: Beijing Agricultural University
  • 1979-1983 Bachelor's: Shanxi Agricultural University
  • 1986-1991 - Beijing Agricultural University - Assistant Lecturer/Lecturer
  • 1994 (3 months) - Calgary University - Postdoctoral Researcher
  • 1995-1998 - Oxford University - Postdoctoral Researcher
  • 1999-2001 - Harvard University/Harvard Medical School - Postdoctoral Researcher
  • 2001-2004 - Oxford University - Lecturer, Doctoral Supervisor, Group Leader
  • 2004-2008 - Institute of Microbiology, Chinese Academy of Sciences - Director
  • 2004-present - Institute of Microbiology, Chinese Academy of Sciences - Researcher, Doctoral Supervisor
  • 2008-present - Beijing Institute of Life Sciences, Chinese Academy of Sciences - Deputy Director
  • 2010-present - Oxford University - Visiting Professor
  • 2011-present - Chinese Center for Disease Control and Prevention - Deputy Director
Pathogenic Microorganisms and Immunology
Molecular Immunology
Molecular Virology
Molecular Epidemiology and Evolution
  • Efficient inhibition of SARS-CoV-2 emerging EG.5, EG.5.1 and BA.2.86 variants by fusion inhibitor HY3000 peptide, Lili Wu, Anqi Zheng, Yangming Tang, Xiaoyun Wang, Yue Gao, Wenwen Lei, Guizhen Wu, Qihui Wang, George Fu Gao, 2024
  • 迈入开放科学新时代, 高福, 2023
  • 主编寄语:开放科学助力全球可持续发展, 高福, 2023
  • A broadly neutralizing nanobody targeting the highly conserved S2 subunit of sarbecoviruses, Xiaoyun Wang, Yufeng Xie, Honghui Liu, Wenwen Lei, Ke Xu, Lili Wu, Ruiwen Fan, Guizhen Wu, George Fu Gao, Qihui Wang, 2023
  • KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors, Lu, Dan, Chen, Yuan, Jiang, Min, Wang, Jie, Li, Yiting, Ma, Keke, Sun, Wenqiao, Zheng, Xing, Qi, Jianxun, Jin, Wenjing, Chen, Yu, Chai, Yan, Zhang, Catherine W H, Liang, Hao, Tan, Shuguang, Gao, George F, 2023
  • De novo design of protein interactions with learned surface fingerprints, Gainza, Pablo, Wehrle, Sarah, Van HallBeauvais, Alexandra, Marchand, Anthony, Scheck, Andreas, Harteveld, Zander, Buckley, Stephen, Ni, Dongchun, Tan, Shuguang, Sverrisson, Freyr, Goverde, Casper, Turelli, Priscilla, Raclot, Charlene, Teslenko, Alexandra, Pacesa, Martin, Rosset, Stephane, Georgeon, Sandrine, Marsden, Jane, Petruzzella, Aaron, Liu, Kefang, Xu, Zepeng, Chai, Yan, Han, Pu, Gao, George F, Oricchio, Elisa, Fierz, Beat, Trono, Didier, Stahlberg, Henning, Bronstein, Michael, Correia, Bruno E, 2023
  • A Wider and Deeper Peptide-Binding Groove for the Class I Molecules from B15 Compared with B19 Chickens Correlates with Relative Resistance to Marek's Disease, Han, Lingxia, Wu, Shaolian, Zhang, Ting, Peng, Weiyu, Zhao, Min, Yue, Can, Wen, Wanxin, Cai, Wenbo, Li, Min, Wallny, HansJoachim, Avila, David W, Mwangi, William, Nair, Venugopa, Ternette, Nicola, Guo, Yaxin, Zhao, Yingze, Chai, Yan, Qi, Jianxun, Liang, Hao, Gao, George F, Kaufman, Jim, Liull, William J, 2023
  • Near-atomic architecture of Singapore grouper iridovirus and implications for giant virus assembly, Zhao, Zhennan, Huang, Youhua, Liu, Congcong, Zhu, Dongjie, Gao, Shuaixin, Liu, Sheng, Peng, Ruchao, Zhang, Ya, Huang, Xiaohong, Qi, Jianxun, Wong, Catherine C L, Zhang, Xinzheng, Wang, Peiyi, Qin, Qiwei, Gao, George F, 2023
  • Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines, Li, Dedong, Duan, Minrun, Wang, Xiao, Gao, Pengyue, Zhao, Xin, Xu, Kun, Gao, George F F, 2023
  • Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine, Guo, Shuxin, Zheng, Yuxuan, Gao, Zhengrong, Duan, Minrun, Liu, Sheng, Du, Pan, Xu, XiaoYu, Xu, Kun, Zhao, Xin, Chai, Yan, Wang, Peiyi, Zhao, Qi, Gao, George F, Dai, Lianpan, 2023
  • Genomic analysis of almost 8,000 Salmonella genomes reveals drivers and landscape of antimicrobial resistance in China, Wang, Yanan, Xu, Xuebin, Zhu, Baoli, Lyu, Na, Liu, Yue, Ma, Sufang, Jia, Shulei, Wan, Bo, Du, Yongkun, Zhang, Gaiping, Gao, George F, 2023
  • Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19, An, Yaling, Zhao, Gan, Duan, Huixin, Zhang, Ning, Duan, Minrun, Xu, Senyu, Liu, Xueyuan, Han, Yuxuan, Zheng, Tianyi, Li, Xin, Hou, Jiawang, Zhang, Zhiyu, Bi, Yuhai, Zhao, Xin, Xu, Kun, Dai, Lianpan, Wang, Bin, Gao, George F, 2023
  • Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents, Liu, Maoshun, Zhang, Jie, Li, Lei, Tian, Jinmin, Yang, Mengjie, Shang, Bingli, Wang, Xin, Li, Min, Li, Hongmei, Yue, Can, Yao, Sijia, Lin, Ying, Guo, Yuanyuan, Zong, Kexin, Zhang, Danni, Zhao, Yingze, Cai, Kun, Dong, Shaobo, Xu, Shengping, Zhan, Jianbo, Gao, George F, Liu, William J, 2023
  • Two-birds-one-stone approach to combine protein and mRNA vaccines for COVID-19, Gao, George F F, 2023
  • Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD, Li, Yulei, Liu, Peipei, Hao, Tianjiao, Liu, Sheng, Wang, Xi, Xie, Yufeng, Xu, Ke, Lei, Wenwen, Zhang, Cheng, Han, Pu, Li, Ying, Jin, Xiyue, Huan, Yu, Lu, Yafei, Zhang, Rong, Li, Xiaoyan, Zhao, Xin, Xu, Kun, Liao, Pu, Lu, Xuancheng, Bi, Yuhai, Song, Hao, Wu, Guizhen, Zhu, Baoli, Gao, George F, 2023
  • Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs, Hu, Yu, Liu, Kefang, Han, Pu, Xu, Zepeng, Zheng, Anqi, Pan, Xiaoqian, Jia, Yunfei, Su, Chao, Tang, Lingfeng, Wu, Lili, Bai, Bin, Zhao, Xin, Tian, Di, Chen, Zhihai, Qi, Jianxun, Wang, Qihui, Gao, George F, 2023
  • 一株靶向沙贝病毒高度保守的S2亚基的广谱中和纳米抗体, 王晓云, 谢宇峰, 刘红辉, 雷雯雯, 徐柯, 仵丽丽, 范瑞文, 武桂珍, 高福, 王奇慧, 2023
  • 平急一体化传染病防控平台在新冠肺炎疫情中的应用, 王奇慧, 齐建勋, 严景华, 高福, 2022
  • Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults, Dai, Lianpan, Gao, Lidong, Tao, Lifeng, Hadinegoro, Sri R, Erkin, Musabaev, Ying, Zhifang, He, Peng, Girsang, Rodman T, Vergara, Hugo, Akram, Javed, Satari, Hindra, I, Khaliq, Tanwir, Sughra, Ume, Celi, Ana P, Li, Fangjun, Li, Yan, Jiang, Zhiwei, Dalimova, Dilbar, Tuychiev, Jaloliddin, Turdikulova, Shahlo, Ikram, Aamer, Flores Lastra, Nancy, Ding, Fan, Suhardono, Mahendra, Fadlyana, Eddy, Yan, Jinghua, Hu, Zhongyu, Li, Changgui, Abdurakhmonov, Ibrokhim Y, Gao, George F, ZF2001 Global Trial Grp, 2022
  • A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants, Zheng, Anqi, Wu, Lili, Ma, Renyi, Han, Pu, Huang, Baoying, Qiao, Chengpeng, Wang, Qihui, Tan, Wenjie, Gao, George F, Han, Pengcheng, 2022
  • Nasal delivery of thermostable and broadly neutralizing antibodies protects mice against SARS-CoV-2 infection, Fan, Wenhui, Sun, Shanshan, Zhang, Ning, Zhang, Yuan, Jiao, Pengtao, Wang, Jian, Gao, George F, Liu, Wenjun, Bi, Yuhai, Yang, Limin, 2022
  • A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates, An, Yaling, Li, Shihua, Jin, Xiyue, Han, JianBao, Xu, Kun, Xu, Senyu, Han, Yuxuan, Liu, Chuanyu, Zheng, Tianyi, Liu, Mei, Yang, Mi, Song, TianZhang, Huang, Baoying, Zhao, Li, Wang, Wen, A, Ruhan, Cheng
Pathogenic Microorganisms Immunology Host Interaction Protein Structure Protein Function T Cell Immunity Molecular Recognition Surface Proteins Receptors Ligands

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.